Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49


The temporal impact of aging on the burden of herpes zoster.

Varghese L, Standaert B, Olivieri A, Curran D.

BMC Geriatr. 2017 Jan 23;17(1):30. doi: 10.1186/s12877-017-0420-9.



Gershon AA, Gershon MD.

Trans Am Clin Climatol Assoc. 2016;127:282-299.


Efficacy of varicella (VZV) vaccination: an update for the clinician.

Wang L, Zhu L, Zhu H.

Ther Adv Vaccines. 2016 Jan;4(1-2):20-31. doi: 10.1177/2051013616655980. Epub 2016 Jan 1.


Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity.

Tran KD, Falcone MM, Choi DS, Goldhardt R, Karp CL, Davis JL, Galor A.

Ophthalmology. 2016 Jul;123(7):1469-75. doi: 10.1016/j.ophtha.2016.03.005. Epub 2016 Apr 8.


The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.

Guzzetta G, Poletti P, Merler S, Manfredi P.

Am J Epidemiol. 2016 Apr 15;183(8):765-73. doi: 10.1093/aje/kwv240. Epub 2016 Mar 18.


An economic analysis of varicella immunization in the Singapore military.

Goh JJ, Ho M, Koh WM, Lee VJ.

Mil Med Res. 2016 Feb 3;3:3. doi: 10.1186/s40779-016-0070-9. eCollection 2016.


Should varicella vaccine be included in the routine immunization programme?

Lin H, Liu Y, Tian L.

Transl Pediatr. 2014 Oct;3(4):273-4. doi: 10.3978/j.issn.2224-4336.2014.10.01. No abstract available.


Herpes zoster segmental paresis in an immunocompromised breast cancer woman.

Rastegar S, Mahdavi SB, Mahmoudi F, Basiri K.

Adv Biomed Res. 2015 Aug 10;4:170. doi: 10.4103/2277-9175.162547. eCollection 2015.


Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.

Pavlopoulou ID, Poulopoulou S, Melexopoulou C, Papazaharia I, Zavos G, Boletis IN.

BMC Infect Dis. 2015 Jul 24;15:285. doi: 10.1186/s12879-015-1038-1.


Dissecting the indirect effects caused by vaccines into the basic elements.

Scarbrough Lefebvre CD, Terlinden A, Standaert B.

Hum Vaccin Immunother. 2015;11(9):2142-57. doi: 10.1080/21645515.2015.1052196. Epub 2015 Jul 17. Review.


Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012.

Humes EA, Weinberger DM, Kudish KS, Hadler JL.

Open Forum Infect Dis. 2015 Jan 28;2(1):ofv001. doi: 10.1093/ofid/ofv001. eCollection 2015 Jan.


Burden of herpes zoster and post-herpetic neuralgia in Sweden.

Nilsson J, Cassel T, Lindquist L.

BMC Infect Dis. 2015 May 22;15:215. doi: 10.1186/s12879-015-0951-7.


The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.

Marziano V, Poletti P, Guzzetta G, Ajelli M, Manfredi P, Merler S.

Proc Biol Sci. 2015 Apr 7;282(1804):20142509. doi: 10.1098/rspb.2014.2509.


Cost-effectiveness of vaccination against herpes zoster.

de Boer PT, Wilschut JC, Postma MJ.

Hum Vaccin Immunother. 2014;10(7):2048-61. doi: 10.4161/hv.28670. Review.


Long-term persistence of zoster vaccine efficacy.

Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH, Looney DJ, Betts R, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman CA, Marques A, Toney J, Boardman K, Su SC, Li X, Chan IS, Parrino J, Annunziato P, Oxman MN; Shingles Prevention Study Group.

Clin Infect Dis. 2015 Mar 15;60(6):900-9. doi: 10.1093/cid/ciu918. Epub 2014 Nov 20.


Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.

Han SB, Kang KR, Huh DH, Lee HC, Kim JH, Kang JH, Ma SH.

Epidemiol Infect. 2015 Jun;143(8):1643-50. doi: 10.1017/S0950268814002441. Epub 2014 Sep 19.


Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.

Heywood AE, Wang H, Macartney KK, McIntyre P.

Bull World Health Organ. 2014 Aug 1;92(8):593-604. doi: 10.2471/BLT.13.132142. Epub 2014 Jun 13.


Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Kawai K, Gebremeskel BG, Acosta CJ.

BMJ Open. 2014 Jun 10;4(6):e004833. doi: 10.1136/bmjopen-2014-004833. Review.


Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Esteban-Vasallo MD, Domínguez-Berjón MF, Gil-Prieto R, Astray-Mochales J, Gil de Miguel A.

Hum Vaccin Immunother. 2014;10(6):1650-60. doi: 10.4161/hv.28620. Epub 2014 May 7.

Supplemental Content

Support Center